These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24376122)

  • 1. Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line.
    Kelly EA; Samuels TL; Johnston N
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):618-24. PubMed ID: 24376122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.
    Johnston N; Yan JC; Hoekzema CR; Samuels TL; Stoner GD; Blumin JH; Bock JM
    Laryngoscope; 2012 Jun; 122(6):1317-25. PubMed ID: 22570308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.
    Johnston N; Wells CW; Samuels TL; Blumin JH
    Ann Otol Rhinol Laryngol; 2009 Sep; 118(9):677-85. PubMed ID: 19810610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease.
    Johnston N; Dettmar PW; Lively MO; Postma GN; Belafsky PC; Birchall M; Koufman JA
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):47-58. PubMed ID: 16466100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The In Vitro Effect of Acidic-Pepsin on Nuclear Factor KappaB Activation and Its Related Oncogenic Effect on Normal Human Hypopharyngeal Cells.
    Sasaki CT; Toman J; Vageli D
    PLoS One; 2016; 11(12):e0168269. PubMed ID: 27973541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pepsin as a causal agent of inflammation during nonacidic reflux.
    Samuels TL; Johnston N
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):559-63. PubMed ID: 19861190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells.
    Doukas PG; Vageli DP; Sasaki CT; Judson BL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.
    Niu K; Guo C; Teng S; Zhou D; Yu S; Yin W; Wang P; Zhu W; Duan M
    PLoS One; 2020; 15(1):e0227408. PubMed ID: 31940393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated uptake of pepsin by laryngeal epithelial cells.
    Johnston N; Wells CW; Blumin JH; Toohill RJ; Merati AL
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):934-8. PubMed ID: 18217514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile reflux and hypopharyngeal cancer (Review).
    Vageli DP; Doukas SG; Doukas PG; Judson BL
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pepsin and Laryngeal and Hypopharyngeal Carcinomas.
    Yin CY; Zhang SS; Zhong JT; Zhou SH
    Clin Exp Otorhinolaryngol; 2021 May; 14(2):159-168. PubMed ID: 32734742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypopharyngeal pepsin and Sep70 as diagnostic markers of laryngopharyngeal reflux: preliminary study.
    Komatsu Y; Kelly LA; Zaidi AH; Rotoloni CL; Kosovec JE; Lloyd EJ; Waheed A; Hoppo T; Jobe BA
    Surg Endosc; 2015 May; 29(5):1080-7. PubMed ID: 25159637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sep70/Pepsin expression in hypopharynx combined with hypopharyngeal multichannel intraluminal impedance increases diagnostic sensitivity of laryngopharyngeal reflux.
    Hoppo T; Zaidi AH; Matsui D; Martin SA; Komatsu Y; Lloyd EJ; Kosovec JE; Civitarese AA; Boyd NH; Shetty A; Omstead AN; Smith E; Jobe BA
    Surg Endosc; 2018 May; 32(5):2434-2441. PubMed ID: 29264754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease.
    Johnston N; Knight J; Dettmar PW; Lively MO; Koufman J
    Laryngoscope; 2004 Dec; 114(12):2129-34. PubMed ID: 15564833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for targeting pepsin in the treatment of reflux disease.
    Johnston N; Wells CW; Samuels TL; Blumin JH
    Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):547-58. PubMed ID: 20860281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium.
    Hurley BP; Jugo RH; Snow RF; Samuels TL; Yonker LM; Mou H; Johnston N; Rosen R
    Sci Rep; 2019 Sep; 9(1):13778. PubMed ID: 31551494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis.
    Sasaki CT; Issaeva N; Vageli DP
    Head Neck; 2016 Apr; 38 Suppl 1():E1381-91. PubMed ID: 26559497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
    Gong Z; Hu G
    Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients.
    Lechien JR; Bobin F; Dapri G; Eisendrath P; Salem C; Mouawad F; Horoi M; Thill MP; Dequanter D; Rodriguez A; Muls V; Saussez S
    Laryngoscope; 2021 Feb; 131(2):268-276. PubMed ID: 32438465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated O-GlcNAcylation Promotes Malignant Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Stabilizing Nrf2 through Regulation of the PI3K/Akt Pathway.
    Dai W; Jin X; Jiang B; Chen W; Ji Z; Xu X; Tang M; Dai K; Han L
    Anticancer Agents Med Chem; 2020; 20(16):1933-1942. PubMed ID: 32538734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.